Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion description "[In this pilot investigation, we found an increased prevalence of the CYP2C8*4 mutation in the Type 2 diabetic patient group. This may result in a modification of drug degradation and drug efficacy in these patients and may have an influence, e.g. on the choice of anti-diabetic drugs. However, further trials are necessary in order to confirm our findings.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion evidence source_evidence_literature NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion SIO_000772 20857895 NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion wasDerivedFrom gad-20130706 NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_assertion wasGeneratedBy ECO_0000203 NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.
- gad-20130706 importedOn "2013-07-06" NP64206.RAgzfoFw6JOApAy7nF-0AYhKbdIpwZ88-48oflu95UeOE130_provenance.